Company intelligence / Profile preview

Saccoo

Cadorago, Lombardy, Italy

Ownership: Private
Employees: ~450
Development stage: Other

Overview

Sacco System is an international biotech hub focused on the research, development, and production of microbial cultures, probiotics, and enzymes. The company operates as a specialized CDMO and ingredients provider for the pharmaceutical, nutraceutical, and food industries, with a significant emphasis on the human microbiome. Their expertise spans from strain selection and characterization to large-scale industrial fermentation and freeze-drying. Sacco System provides clinically documented probiotic strains for applications in gastrointestinal health, dermatology, and immune modulation.

Therapeutic areas: GastroenterologyWomen's HealthDermatologyImmunology
Modalities: Live biotherapeutic product therapyBiologicMicrobial therapy
Industry: Biotech

Drug pipeline

1 asset

Bifidobacterium animalis subsp. lactis BLC1

Unknown

Beyond the preview

Go deeper on Saccoo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Saccoo.

Explore the full profile